Treatment of cutaneous leishmaniasis with itraconazole: Randomized double-blind study

Archives of Dermatology

Volumn 132, Issue 7, 1996, Pages 784-786

  Momeni, Ali Z ^a,b   Jalayer, Tahmores ^a   Emamjomeh, Morteza ^a   Bashardost, Nasrolah ^a   Ghassemi, Reza L ^a   Meghdadi, Morteza ^a   Javadi, Abasali ^a   Aminjavaheri, Malih ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE; PLACEBO;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENDEMIC DISEASE; FEMALE; HUMAN; LEISHMANIA MAJOR; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN LEISHMANIASIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIFUNGAL AGENTS; CHILD; DOUBLE-BLIND METHOD; FEMALE; HUMANS; ITRACONAZOLE; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED;

EID: 0030006775     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.132.7.784     Document Type: Article

References (16)

1. Nadim A, Seyedi Rashti MA. Brief review of the epidemiology of various types of leishmaniasis in Iran. Acta Med Iran. 1971;99:106-110.
2. Momeni AZ, Aminjavaheri M. Clinical picture of cutaneous leishmaniasis in Isfahan, Iran. Int J Dermatol 1994;33:260-265.
3. Weinrauch L, El-On J. Current therapy of cutaneous leishmaniasis. Int J Dermatol. 1987;9:564-570.
4. Heung-Chong BA. Oriental sore: a look at trends in and approaches to the treatment of Jeishmaniasis. Int J Dermatol. 1986;25:615-622.
5. Borelli D. A clinical trial of itraconazole in the treatment of deep mycosis and leishmaniasis. Rev Infect Dis. 1987;9(suppl 1):57-63.
6. Beach DH, Goal LJ, Holz GG Jr. Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes. Mol Biochem Parasitol. 1983; 31:149-162.
7. Beule K, Cauwenbergh G. The treatment of cutaneous leishmaniasis with ketoconazole and itraconazole. Presented at the 16th International Congress of Chemotherapy: June 11-16, 1989; Jerusalem, Israel.
8. Albanese G, Giorgetti P, Santagostino L, Crippa M. Cutaneous leishmaniasis: treatment with itraconazole. Arch Dermatol. 1989;125:1540-1542.
9. Akufo H, Dietz M, Teklemaram S et al. The use of itraconazole in the treatment of leishmaniasis caused by Leishmania aethiopica. Trans R Soc Trop Med Hyg. 1990;84:532-534.
10. Al-Fouzan AS, Al-Saleh QA, Najem NM, Rostom AI. Cutaneous leishmaniasis in Kuwait: clinical experience with itraconazole. Int J Dermatol. 1991;30:419-521.
11. Park BC, Chae HJ, Yunk YJ, et al Two cases of cutaneous leishmaniasis treated with itraconazole. Ann Dermatol. 1992;4:91-94.
12. Al Rubaie MS. Cutaneous leishmaniasis in UAE: treatment with itraconazole. Presented at the Dermatology 2000 Congress: May 18-21, 1993; Vienna, Austria.
13. Dogra J. Cutaneous leishmaniasis and itraconazole: a randomized double-blind study. Presented at the Sixth International Congress of Infectious Diseases; April 26-30, 1994; Prague, Czech Republic.
14. Van den Enden E, Van Gompel A, Stevens A. et al. Treatment of cutaneous leishmaniasis with oral itraconazole Int J Dermatol. 1994;33:285-286.
15. Nadim A, Faghin M. The epidemiology of cutaneous leishmaniasis in the Isfahan province of Iran, II: human infection. Trans R Soc Trop Med Hyg. 1971; 62:534-543.
16. Pialoux G, Hennequin C, Dupont B, Ravisse P. Cutaneous leishmaniasis in an AIDS patient cured with itraconazole. J Infect Dis. 1990;162:1221-1222.